Trial Outcomes & Findings for Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy (NCT NCT00654641)

NCT ID: NCT00654641

Last Updated: 2013-01-30

Results Overview

Superficial or deep space surgical site infection, or any type of wound disruption, including wound hematoma or seroma.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

54 participants

Primary outcome timeframe

6 Weeks post-partum

Results posted on

2013-01-30

Participant Flow

Participant milestones

Participant milestones
Measure
Negative Pressure Wound Closure
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
Standard Wound Closure
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
Overall Study
STARTED
28
26
Overall Study
COMPLETED
26
23
Overall Study
NOT COMPLETED
2
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Negative Pressure Wound Closure
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
Standard Wound Closure
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
Overall Study
Lost to Follow-up
2
3

Baseline Characteristics

Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Negative Pressure Wound Closure
n=28 Participants
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
Standard Wound Closure
n=26 Participants
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
Total
n=54 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
n=99 Participants
26 Participants
n=107 Participants
54 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Female
28 Participants
n=99 Participants
26 Participants
n=107 Participants
54 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
28 participants
n=99 Participants
26 participants
n=107 Participants
54 participants
n=206 Participants

PRIMARY outcome

Timeframe: 6 Weeks post-partum

Superficial or deep space surgical site infection, or any type of wound disruption, including wound hematoma or seroma.

Outcome measures

Outcome measures
Measure
Negative Pressure Wound Closure
n=28 Participants
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
Standard Wound Closure
n=26 Participants
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
Total Number of Patients Experiencing a Wound Complication
15 Participants
10 Participants

Adverse Events

Negative Pressure Wound Closure

Serious events: 0 serious events
Other events: 15 other events
Deaths: 0 deaths

Standard Wound Closure

Serious events: 0 serious events
Other events: 10 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Negative Pressure Wound Closure
n=28 participants at risk
Negative Pressure wound closure utilizing wall suction and a drain placed exterior to the closed wound.
Standard Wound Closure
n=26 participants at risk
Wound closed in standard fashion utilizing subcutaneous absorb-able suture and skin staples.
Skin and subcutaneous tissue disorders
Wound complication
53.6%
15/28 • Number of events 15
38.5%
10/26 • Number of events 10

Additional Information

Michael L. Stitely, MD

West Viginia University

Phone: 304-293-1566

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place